What is the Return on Assets (ROA) of Elan this year?
The Return on Assets (ROA) of Elan is 0.13 undefined this year.
Elan ROA 2024
Elan ROA
0.13
Ticker
6099.T
ISIN
JP3167680002
WKN
A12C13
In 2024, Elan's return on assets (ROA) was 0.13, a 2.34% increase from the 0.13 ROA in the previous year.
Elan Aktienanalyse
What does Elan do?
Elan Corp is an Irish pharmaceutical company specializing in the research, development, and marketing of medications for neurological and autoimmune diseases. The company was founded in 1969 under the name Athlone Laboratories and has since undergone significant changes in both its business fields and its name. In 1996, the company was renamed Elan Corporation, a name it still holds today. At that time, the company primarily focused on researching and developing medications for Alzheimer's and Parkinson's diseases. However, in the following years, the company shifted its focus more towards treating autoimmune diseases such as multiple sclerosis and Crohn's disease. Elan Corp's business model is based on the development of medications through research and development as well as the acquisition of established therapeutics. One key component of the product portfolio is the medication Tysabri, which was developed in collaboration with Biogen Idec. It is used to treat multiple sclerosis patients and is one of Elan's top-selling medications, contributing significantly to the company's success. Elan Corp consists of three main business areas: 1. Biopharmaceuticals This division is responsible for the research and development of medications for neurological diseases such as Alzheimer's, Parkinson's, and multiple sclerosis. Some of the key products in this area, in addition to Tysabri, include Axona, a nutritional supplement to enhance cognitive function in Alzheimer's patients, and Zanaflex, which is used to treat muscle spasms in the majority of multiple sclerosis patients. 2. Neurology In this division, Elan focuses on the marketing and distribution of nerve and pain medications, as well as products for treating infections. Some of the key products in this area are Skelaxin, a muscle relaxant for pain and muscle spasms, and Biaxin, an antibiotic for treating infections. 3. Medical Technology Elan Corp's medical technology division specializes in the development and marketing of infusion pumps. The company primarily offers its products and services in the United States and Europe and holds a strong position in this market. Elan Corp is a company with a strong focus on research and development. Its key products are medications for treating neurological and autoimmune diseases, with Tysabri being the most well-known and successful. The company has undergone significant changes over the years and now focuses on developing medications for autoimmune diseases in the neurology field. With a strong emphasis on research and development, as well as the acquisition of established therapeutics, Elan Corp is an important player in the pharmaceutical industry and is expected to continue growing and succeeding in the future. Elan ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding Elan's Return on Assets (ROA)
Elan's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing Elan's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider Elan's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in Elan’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about Elan stock
What was the ROA of Elan compared to the previous year?
The ROA of Elan has increased by 2.34% compared to the previous year.
What consequences do high ROA have for investors of Elan?
A high ROA is advantageous for investors of Elan, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in Elan?
A low ROA can be unfavorable for investors of Elan as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of Elan affect the company?
An increase in ROA of Elan can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of Elan impact the company?
A reduction in the ROA of Elan can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of Elan?
Some factors that can influence the ROA of Elan include revenue, operating costs, asset structure, and industry average.
Why is the ROA of Elan important for investors?
The ROA of Elan is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can Elan take to improve ROA?
To improve ROA, Elan can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does Elan pay?
Over the past 12 months, Elan paid a dividend of 13 JPY . This corresponds to a dividend yield of about 1.93 %. For the coming 12 months, Elan is expected to pay a dividend of 15.09 JPY.
What is the dividend yield of Elan?
The current dividend yield of Elan is 1.93 %.
When does Elan pay dividends?
Elan pays a quarterly dividend. This is distributed in the months of January, January, January, January.
How secure is the dividend of Elan?
Elan paid dividends every year for the past 13 years.
What is the dividend of Elan?
For the upcoming 12 months, dividends amounting to 15.09 JPY are expected. This corresponds to a dividend yield of 2.24 %.
In which sector is Elan located?
Elan is assigned to the 'Health' sector.
Wann musste ich die Aktien von Elan kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Elan from 3/1/2025 amounting to 14 JPY, you needed to have the stock in your portfolio before the ex-date on 12/27/2024.
When did Elan pay the last dividend?
The last dividend was paid out on 3/1/2025.
What was the dividend of Elan in the year 2023?
In the year 2023, Elan distributed 11 JPY as dividends.
In which currency does Elan pay out the dividend?
The dividends of Elan are distributed in JPY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Elan
Our stock analysis for Elan Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Elan Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
